{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:15:54Z","timestamp":1787494554561,"version":"build-2736575974"},"reference-count":149,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17301"],"award-info":[{"award-number":["20K17301"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K08714"],"award-info":[{"award-number":["19K08714"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bone contributes to supporting the body, protecting the central nervous system and other organs, hematopoiesis, the regulation of mineral metabolism (mainly calcium and phosphate), and assists in respiration. Bone has many functions in the body. Recently, it was revealed that bone also works as an endocrine organ and secretes several systemic humoral factors, including fibroblast growth factor 23 (FGF23), osteocalcin (OC), sclerostin, and lipocalin 2. Bone can communicate with other organs via these hormones. In particular, it has been reported that these bone-derived hormones are involved in glucose metabolism and diabetic complications. Some functions of these bone-derived hormones can become useful biomarkers that predict the incidence of diabetes and the progression of diabetic complications. Furthermore, other functions are considered to be targets for the prevention or treatment of diabetes and its complications. As is well known, diabetes is now a worldwide health problem, and many efforts have been made to treat diabetes. Thus, further investigations of the endocrine system through bone-derived hormones may provide us with new perspectives on the prediction, prevention, and treatment of diabetes. In this review, we summarize the role of bone-derived hormones in glucose metabolism, diabetic kidney disease, and cardiovascular disorders.<\/jats:p>","DOI":"10.3390\/ijms23042376","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:47:45Z","timestamp":1645476465000},"page":"2376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-1139","authenticated-orcid":false,"given":"Yuichi","family":"Takashi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-4701","authenticated-orcid":false,"given":"Daiji","family":"Kawanami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Kaptoge","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2337\/diacare.22.7.1196","article-title":"Bone mineral density in patients with type 1 and type 2 diabetes","volume":"22","author":"Tuominen","year":"1999","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11914-014-0202-7","article-title":"Diabetes, collagen, and bone quality","volume":"12","author":"Saito","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s00198-017-4183-0","article-title":"Risk of low-energy fracture in type 2 diabetes patients: A meta-analysis of observational studies","volume":"28","author":"Jia","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/dc19-0925","article-title":"Vertebral fractures in individuals with type 2 diabetes: More than skeletal complications alone","volume":"43","author":"Koromani","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hofbauer, L.C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Muller, R., Burden, A.M., Rivadeneira, F., Napoli, N., and Rauner, M. (2022). Bone fragility in diabetes: Novel concepts and clinical implications. Lancet Diabetes Endocrinol.","DOI":"10.1016\/S2213-8587(21)00347-8"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","article-title":"Bone as an endocrine organ","volume":"20","author":"Fukumoto","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"Consortium","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.3001","article-title":"Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots","volume":"32","author":"Fulzele","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature21697","article-title":"MC4R-dependent suppression of appetite by bone-derived lipocalin 2","volume":"543","author":"Mosialou","year":"2017","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Matsumura","year":"1997","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature25451","article-title":"alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00774-015-0651-9","article-title":"Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells","volume":"34","author":"Hori","year":"2016","journal-title":"J. Bone Miner. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.1815166116","article-title":"Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation","volume":"116","author":"Takashi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","article-title":"Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow","volume":"102","author":"Clinkenbeard","year":"2017","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","article-title":"Up-regulation of FGF23 release by aldosterone","volume":"470","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tem.2018.08.006","article-title":"FGF23 beyond Phosphotropic Hormone","volume":"29","author":"Takashi","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.ejcn.1602375","article-title":"Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects","volume":"60","author":"Haap","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ki.1991.15","article-title":"Phosphate depletion impairs insulin secretion by pancreatic islets","volume":"39","author":"Zhou","year":"1991","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12937-015-0101-5","article-title":"Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: A crossover experiment","volume":"14","author":"Khattab","year":"2015","journal-title":"Nutr. J."},{"key":"ref_40","first-page":"62","article-title":"Effectiveness of phosphate supplementation in glucose intolerant, hypophosphatemic patients","volume":"23","author":"Wittmann","year":"1997","journal-title":"Miner. Electrolyte Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1507\/endocrj.42.377","article-title":"Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus","volume":"42","author":"Nagasaka","year":"1995","journal-title":"Endocr. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/jcem-50-5-862","article-title":"Mineral metabolism in diabetes mellitus: Changes accompanying treatment with a portable subcutaneous insulin infusion system","volume":"50","author":"Gertner","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF03216224","article-title":"The effect of chronic insulin therapy on phosphate metabolism in diabetes mellitus","volume":"21","author":"Raskin","year":"1981","journal-title":"Diabetologia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1042\/CS20201290","article-title":"Phosphate and fibroblast growth factor 23 in diabetes","volume":"135","author":"Yeung","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","article-title":"Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice","volume":"26","author":"Hesse","year":"2007","journal-title":"Matrix Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1515\/jpem-2012-0064","article-title":"The association of FGF23 levels in obese adolescents with insulin sensitivity","volume":"25","author":"Wojcik","year":"2012","journal-title":"J. Pediatric Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.2011.04299.x","article-title":"FGF23 contributes to insulin sensitivity in obese adolescents\u2014Preliminary results","volume":"77","author":"Wojcik","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdiacomp.2013.09.004","article-title":"Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients","volume":"28","author":"Garland","year":"2014","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hanks, L.J., Casazza, K., Judd, S.E., Jenny, N.S., and Guti\u00e9rrez, O.M. (2015). Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122885"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"13999","DOI":"10.1038\/s41598-018-32432-z","article-title":"Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus","volume":"8","author":"Nakashima","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"34696","DOI":"10.1038\/srep34696","article-title":"Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc11-2235","article-title":"Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease","volume":"35","author":"Wahl","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.2337\/dc13-2235","article-title":"FGF23 in type 2 diabetic patients: Relationship with bone metabolism and vascular disease","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.1800160115","article-title":"Insulin suppresses the production of fibroblast growth factor 23 (FGF23)","volume":"115","author":"Bar","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD","volume":"7","author":"Isakova","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"Isakova","year":"2017","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jdiacomp.2018.06.013","article-title":"The interrelation between FGF23 and glucose metabolism in humans","volume":"32","author":"Ursem","year":"2018","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","article-title":"CKD in diabetes: Diabetic kidney disease versus nondiabetic kidney disease","volume":"14","author":"Anders","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/dmrr.2787","article-title":"Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease","volume":"32","author":"Carda","year":"2016","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc17-0820","article-title":"FGF23 concentration and APOL1 genotype are novel predictors of mortality in African Americans with type 2 diabetes","volume":"41","author":"Chan","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Frimodt-M\u00f8ller, M., von Scholten, B.J., Reinhard, H., Jacobsen, P.K., Hansen, T.W., Persson, F.I., Parving, H.H., and Rossing, P. (2018). Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes\u2014An observational follow-up study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196634"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2337\/dc19-0528","article-title":"Fibroblast growth factor 23 and mortality in patients with type 2 diabetes and normal or mildly impaired kidney function","volume":"42","author":"Yeung","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Silva, A.P., Mendes, F., Carias, E., Gon\u00e7alves, R.B., Fragoso, A., Dias, C., Tavares, N., Caf\u00e9, H.M., Santos, N., and Rato, F. (2019). Plasmatic Klotho and FGF23 levels as biomarkers of CKD-associated cardiac disease in type 2 diabetic patients. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071536"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhang, X., Guo, K., Xia, F., Zhao, X., Huang, Z., and Niu, J. (2018). FGF23(C-tail) improves diabetic nephropathy by attenuating renal fibrosis and inflammation. BMC Biotechnol., 18.","DOI":"10.1186\/s12896-018-0449-7"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","article-title":"Bone formation regulates circulating concentrations of fibroblast growth factor 23","volume":"150","author":"Samadfam","year":"2009","journal-title":"Endocrinology"},{"key":"ref_71","first-page":"101107","article-title":"Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span","volume":"27","author":"Takashi","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1542-4758.2010.00480.x","article-title":"Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients","volume":"14","author":"Balci","year":"2010","journal-title":"Hemodial. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","article-title":"Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients","volume":"25","author":"Nasrallah","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone","volume":"69","author":"Hauschka","year":"1989","journal-title":"Physiol. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002239900682","article-title":"Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: The Taiji study","volume":"65","author":"Yoshimura","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1359\/jbmr.2000.15.3.515","article-title":"Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis","volume":"15","author":"Shiraki","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI72323","article-title":"Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation","volume":"124","author":"Wei","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-014-9307-7","article-title":"An overview of the metabolic functions of osteocalcin","volume":"16","author":"Wei","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2337\/db13-0887","article-title":"Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a","volume":"63","author":"Wei","year":"2014","journal-title":"Diabetes"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2337\/db14-1642","article-title":"DLK1 regulates whole-body glucose metabolism: A negative feedback regulation of the osteocalcin-insulin loop","volume":"64","author":"Abdallah","year":"2015","journal-title":"Diabetes"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.cell.2011.02.004","article-title":"Endocrine regulation of male fertility by the skeleton","volume":"144","author":"Oury","year":"2011","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Mizokami, A., Yasutake, Y., Gao, J., Matsuda, M., Takahashi, I., Takeuchi, H., and Hirata, M. (2013). Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057375"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.08.042","article-title":"Maternal and offspring pools of osteocalcin influence brain development and functions","volume":"155","author":"Oury","year":"2013","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2016.05.004","article-title":"Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise","volume":"23","author":"Mera","year":"2016","journal-title":"Cell Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cellsig.2014.12.018","article-title":"Signaling pathway for adiponectin expression in adipocytes by osteocalcin","volume":"27","author":"Otani","year":"2015","journal-title":"Cell. Signal."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1471-4159.2005.03025.x","article-title":"Cloning and characterization of a family C orphan G-protein coupled receptor","volume":"93","author":"Kuang","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"40201","DOI":"10.1074\/jbc.M505186200","article-title":"Identification of a novel extracellular cation-sensing G-protein-coupled receptor","volume":"280","author":"Pi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1084\/jem.20171320","article-title":"Gpr158 mediates osteocalcin\u2019s regulation of cognition","volume":"214","author":"Khrimian","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jdi.12601","article-title":"Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes","volume":"8","author":"Takashi","year":"2017","journal-title":"J. Diabetes Investig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1210\/EN.2015-1143","article-title":"Osteocalcin effect on human beta-cells mass and function","volume":"156","author":"Sabek","year":"2015","journal-title":"Endocrinology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-011-1600-7","article-title":"Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo osteoporosis risk in men (FORMEN) study","volume":"23","author":"Iki","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jc.2014-3019","article-title":"Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men","volume":"100","author":"Yeap","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3945\/ajcn.111.016642","article-title":"Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and beta cell function in elderly men at high cardiovascular risk","volume":"95","author":"Bullo","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/dmrr.2808","article-title":"Significant inverse association between serum osteocalcin and incident type 2 diabetes in a middle-aged cohort","volume":"32","author":"Shu","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00774-017-0857-0","article-title":"Low serum osteocalcin concentration is associated with incident type 2 diabetes mellitus in Japanese women","volume":"36","author":"Urano","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/dc18-0849","article-title":"Biochemical markers of bone turnover and risk of incident diabetes in older women: The cardiovascular health study","volume":"41","author":"Massera","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Ye, X., Yu, R., Jiang, F., Hou, X., Wei, L., Bao, Y., and Jia, W. (2022). Osteocalcin and risks of incident diabetes and diabetic kidney disease: A 4.6-year prospective cohort study. Diabetes Care.","DOI":"10.2337\/figshare.18092852.v1"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-010-1184-7","article-title":"Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus","volume":"22","author":"Kanazawa","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00198-012-2017-7","article-title":"Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus","volume":"24","author":"Kanazawa","year":"2013","journal-title":"Osteoporos. Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdiacomp.2017.09.004","article-title":"Decreased serum undercarboxylated osteocalcin is associated with cognitive impairment in male patients with type 2 diabetes","volume":"32","author":"Fang","year":"2018","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10654-015-0058-x","article-title":"Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: Systematic review and meta-analysis of observational evidence","volume":"30","author":"Kunutsor","year":"2015","journal-title":"Eur. J. Epidemiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00198-011-1807-7","article-title":"Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes","volume":"23","author":"Thrailkill","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2015.04.017","article-title":"Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes","volume":"82","author":"Neumann","year":"2016","journal-title":"Bone"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jdiacomp.2017.03.016","article-title":"Circulating osteocalcin is unrelated to glucose homoeostasis in adults with type 1 diabetes","volume":"31","author":"Yeap","year":"2017","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Takashi, Y., Ishizu, M., Mori, H., Miyashita, K., Sakamoto, F., Katakami, N., Matsuoka, T.A., Yasuda, T., Hashida, S., and Matsuhisa, M. (2019). Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216416"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1475-2840-13-74","article-title":"Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt\/eNOS-dependent pathway","volume":"13","author":"Dou","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jdiacomp.2019.01.003","article-title":"Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease","volume":"33","author":"Darwish","year":"2019","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00223-018-0460-y","article-title":"The association between osteocalcin and chronic inflammation in patients with type 2 diabetes mellitus","volume":"103","author":"Kanazawa","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1074248419876632","article-title":"The potential role of undercarboxylated osteocalcin upregulation in microvascular insufficiency in a rat model of diabetic cardiomyopathy","volume":"25","author":"Sadek","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/713773607","article-title":"The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: The role of microvascular growth and abnormalities","volume":"10","author":"Pinto","year":"2003","journal-title":"Microcirculation"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20040057","article-title":"Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment","volume":"107","author":"Hayat","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00198-005-1877-5","article-title":"Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus","volume":"16","author":"Gerdhem","year":"2005","journal-title":"Osteoporos. Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1210\/jc.2014-3481","article-title":"Bisphosphonates and glucose homeostasis: A population-based, retrospective cohort study","volume":"100","author":"Toulis","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: Rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: A randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40610-017-0057-7","article-title":"Connecting bone and fat: The potential role for sclerostin","volume":"3","author":"Fairfield","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1210\/jc.2012-1218","article-title":"Association of circulating sclerostin levels with fat mass and metabolic disease--related markers in Japanese postmenopausal women","volume":"97","author":"Urano","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: Evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","article-title":"Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes","volume":"114","author":"Kim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cen.13300","article-title":"The association between sclerostin and incident type 2 diabetes risk: A cohort study","volume":"86","author":"Yu","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Saadeldin, M.K., Elshaer, S.S., Emara, I.A., Maged, M., and Abdel-Aziz, A.K. (2018). Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206761"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1567202614666170619080526","article-title":"The Wnt\/\u03b2-catenin signalling pathway inhibitor sclerostin is a biomarker for early atherosclerosis in obesity","volume":"14","author":"Popovic","year":"2017","journal-title":"Curr. Neurovascular Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jdiacomp.2019.04.012","article-title":"Serum sclerostin level and its relation to subclinical atherosclerosis in subjects with type 2 diabetes","volume":"33","author":"Shalash","year":"2019","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"107469","DOI":"10.1016\/j.jdiacomp.2019.107469","article-title":"Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes","volume":"34","author":"Davoodi","year":"2020","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1479164118816661","article-title":"Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study","volume":"16","author":"Yang","year":"2019","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/cvr\/cvs141","article-title":"Wnt signalling in smooth muscle cells and its role in cardiovascular disorders","volume":"95","author":"Mill","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"H2864","DOI":"10.1152\/ajpheart.00982.2007","article-title":"Wnt5a is expressed in murine and human atherosclerotic lesions","volume":"294","author":"Christman","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00198-016-3718-0","article-title":"Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus","volume":"28","author":"Pereira","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"112002","DOI":"10.1016\/j.biopha.2021.112002","article-title":"Lipocalin-2: Structure, function, distribution and role in metabolic disorders","volume":"142","author":"Jaberi","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2337\/db07-0007","article-title":"The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance","volume":"56","author":"Yan","year":"2007","journal-title":"Diabetes"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"E825","DOI":"10.1152\/ajpendo.00147.2011","article-title":"A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance","volume":"301","author":"Jun","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","article-title":"Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans","volume":"53","author":"Wang","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3109\/1354750X.2015.1123354","article-title":"The potential of lipocalin-2\/NGAL as biomarker for inflammatory and metabolic diseases","volume":"20","author":"Abella","year":"2015","journal-title":"Biomarkers"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1097\/01.ASN.0000145013.44578.45","article-title":"Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin","volume":"15","author":"Mishra","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jhep.2016.05.041","article-title":"Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2","volume":"65","author":"Ye","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.amjcard.2009.05.023","article-title":"Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease","volume":"104","author":"Zografos","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e011028","DOI":"10.1161\/JAHA.118.011028","article-title":"Association between plasma neutrophil gelatinase-associated lipocalin and cardiac disease hospitalizations and deaths in older women","volume":"8","author":"Chong","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/1753-0407.12540","article-title":"Economic and social impact of diabetes mellitus in a low-income country: A case-control study in Sudan","volume":"9","author":"Eltom","year":"2017","journal-title":"J. Diabetes"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:24:09Z","timestamp":1760135049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":149,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23042376"],"URL":"https:\/\/doi.org\/10.3390\/ijms23042376","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}